Thaikanya Insight: CBD & Brain–Behavioral Health

Researchers reported “improvements in core behavioral domains” following the use of CBD-dominant extracts in children.


A study published in Current Neuropharmacology reports that CBD-rich cannabis oil extracts were associated with improvements in behavioral symptoms among children diagnosed with Autism Spectrum Disorder (ASD) with comorbid Attention Deficit Hyperactivity Disorder (ADHD).

Study Overview
• Duration: 3–6 months
• Assessment tool: Conners’ Teaching Rating Scale (CTRS)
• Evaluators: School teachers, providing standardized, third-party observations

Key Findings

Significant improvements were observed in:
• Anxious-shyness
• Emotional regulation
• ADHD index
• Hyperactive-impulsivity

Participants also showed trends toward reduced hyperactivity and improved attention span, although these did not reach statistical significance.

Researchers’ Conclusion

“This is the first prospective study evaluating CBD-rich cannabis for ADHD symptoms in children with ASD using standardized teacher-based assessments.
The findings suggest improvements in core behavioral domains and support emerging evidence that cannabinoids may play a role in modulating attention and emotional regulation.
Further placebo-controlled clinical trials are warranted to confirm efficacy and determine optimal dosing.”

⸻

⚠️ Thaikanya Medical Ethics Note
• ข้อมูลนี้เป็น การสื่อสารเชิงวิชาการ ไม่ใช่คำแนะนำให้ใช้แทนการรักษาแพทย์
• การใช้ CBD ในเด็ก ต้องอยู่ภายใต้การดูแลของแพทย์เท่านั้น
• ขนาดยา รูปแบบสารสกัด และความเหมาะสม ต้องพิจารณาเป็นรายบุคคล

⸻

Thaikanya Perspective

CBD is not a cure — but evidence suggests it may be a supportive tool
when used responsibly, legally, and under medical supervision
as part of a holistic, child-centered care approach.